24 January 2021: Clinical Research
Elevated Plasma Angiopoietinlike Protein 5 (ANGPTL5) Is More Positively Associated with Glucose Metabolism Disorders in Patients with Metabolic Syndrome
Chang Liu 123ABCD* , Xin Yi 123AEG* , Yongnan Lyu 123CF , Wei Ren 4CD , Yi Zhou 123BF , Gaoke Feng 123E , Weiguo Wan 123B , Xue-jun Jiang 123AEG*DOI: 10.12659/MSM.929626
Med Sci Monit 2021; 27:e929626
Table 5 Multivariate logistic regression to assess association of plasma angiopoietinlike protein 5 (ANGPTL5) with the risk of metabolic syndrome (MS).
| ANGPTL5 | OR (95% CI) | P value |
|---|---|---|
| Unadjusted | 1.026 (1.018–1.035) | |
| Model1 | 1.030 (1.011–1.049) | 0.002 |
| Model2 | 1.044 (1.013–1.076) | 0.005 |
| Model3 | 1.044 (1.013–1.075) | 0.005 |
| Model 1: adjusted for sex, age, body mass index; Model 2: adjusted for model 1+family history of diabetes, family history of hypertension, smoking; Model 3: adjusted for model 2+high-sensitivity C-reactive protein. | ||